Comparison of two particulate hexavalent chromium compounds: Barium chromate is more genotoxic than lead chromate in human lung cells

Environmental and Molecular Mutagenesis

Volumn 44, Issue 2, 2004, Pages 156-162

  Wise, Sandra S ^a   Schuler, Julie H C ^a,b   Holmes, Amie L ^a   Katsifis, Spiros P ^b   Ketterer, Michael E ^c   Hartsock, Wendy J ^c   Zheng, Tonqzhanq ^d   Wise Sr , John Pierce ^a  

^a UNIVERSITY OF SOUTHERN MAINE   (United States)

^b UNIVERSITY OF BRIDGEPORT   (United States)

^c NORTHERN ARIZONA UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchial; Cell culture; Chromate, barium chromate; Chromium; Chromosome aberrations; Cytotoxicity; Genotoxicity

Indexed keywords

BARIUM CHROMATE; CHROMIC ACID; CHROMIUM; DNA; LEAD CHROMATE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL SURVIVAL; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; GENOTOXICITY; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; PARTICLE SIZE;

BARIUM COMPOUNDS; CELL LINE; CHROMATES; HUMANS; LEAD; LUNG; MUTAGENICITY TESTS; MUTAGENS;

EID: 4043086926     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.20044     Document Type: Article

References (26)

1. Agency for Toxic Substances and Disease Registry. 1992. Toxicological profile for barium: TP-91-03. Atlanta, GA: Public Health Service, U.S. Department of Health and Human Services.
2. Ayre AC, LeGuerrier J. 1967. Some (regressive) effects of DMSO dexamethasone upon cervical cells in cervical dysplasia and carcinoma in situ. Ann NY Acad Sci 141:414-422.
3. Biedermann KA, Landolph JR. 1990. Role of valence state and solubility of chromium compounds on induction of cytotoxicity, mutagenesis and anchorage independence in diploid human fibroblasts. Cancer Res 50:7835-7842.
4. Blankenship LJ, Carlisle D, Wise JP Sr, Orenstein JM, Dye LE, Patierno SR. 1997. Induction of apoptotic cell death by particulate lead chromate: differential effects of vitamins C and E on genotoxicity and survival. Toxicol Appl Pharm 146:270-280.
5. Dallas CE, Williams PL. 2001. Barium: rationale for a new oral reference dose. J Toxicol Environ Health Part B 4:395-429.
6. Elias Z, Poirot O, Pezerat H, Suquet H, Schneider O, Daniere MC, Terzetti F, Baruthio F, Fournier M, Cavelier C. 1989. Cytotoxic and neoplastic transforming effects of industrial hexavalent chromium pigments in Syrian hamster embryo cells. Carcinogenesis 10:2043-2052.
7. International Agency for Research on Cancer. 1990. Chromium, nickel and welding. Lyons, France: International Agency for Research on Cancer.
8. Ishikawa Y, Nakagawa K, Satoh Y, Kitagawa T, Sugano H, Hirano T, Tsuchiya E. 1994a. Characteristics of chromate workers' cancers, chromium lung deposition and precancerous bronchial lesions: an autopsy study. Br J Cancer 70:160-166.
9. Ishikawa Y, Nakagawa K, Satoh Y, Kitagawa T, Sugano H, Hirano T, Tsuchiya E. 1994b. "Hot spots" of chromium accumulation at bifurcations of chromate workers' bronchi. Cancer Res 54:2342-2346.
10. Klein CB, Su L, Bowser D, Leszczynska J. 2002. Chromate-induced epimutations in mammalian cells. Environ Health Perspect 101: 739-743.
11. Léonard A, Lauwerys RR. 1980. Carcinogenicity and mutagenicity of chromium. Mutat Res 76:277-239.
12. Levy LS, Vanitt S. 1986. Carcinogenicity and mutagenicity of chromium compounds: the association between bronchial metaplasia and neoplasia. Carcinogenesis 7:831-835.
13. Matthews EJ, Spalding JW, Tennant RW. 1993. Transformation of BALB/c-3T3 cells: IV, rank-ordered potency of 24 chemical responses detected in a sensitive new assay procedure. Enivron Health Perspect 101:319-345.
14. Patierno SR, Banh D, Landolph JR. 1988. Transformation of C3H/10T1/2 mouse embryo cells by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles. Cancer Res 47:3815-3823.
15. Singh J, Pritchard DE, Carlisle DL, Mclean JA, Montaser A, Orenstein JM, Patierno SR. 1999. Internalization of carcinogenic lead chromate particles by cultured normal human lung epithelial cells: formation of intracellular lead-inclusion bodies and induction of apoptosis. Toxicol Appl Pharm 161:240-248.
16. Venier P, Montaldi A, Gava C, Zentilin L, Tecchio G, Bianchi S, Levis, AG. 1985. Effects of nitrilotriacetic acid on the induction of gene mutations and sister-chromatid exchanges by insoluble chromium compounds. Mutat Res 156:219-228.
17. 4 in hamster and human cells. Mutat Res 278:69-79.
18. Wise JP Sr, Orenstein JM, Patierno SR. 1993. Inhibition of lead chromate clastogenesis by ascorbate: relationship to particle dissolution and uptake. Carcinogenesis 14:429-434.
19. Wise JP Sr, Wise SS, Little JE. 2002. The cytotoxicity and genotoxicity of particulate and soluble hexavalent chromium in human lung cells. Mutat Res 517:221-229.
20. Wise SS, Elmore LW, Holt SE, Little JE, Bryant BH, Wise JP Sr. 2004. Telomerase-mediated lifespan extension of human bronchial cells does not affect hexavalent chromium-induced cytotoxicity or genotoxicity. Mol Cell Biochem 255:103-111.
21. Wise SS, Schuler JHC, Katsifis SP, Wise JP Sr. 2003a. Barium chromate is cytotoxic and genotoxic to human lung cells. Environ Mol Mutagen 42:274-278.
22. Wise SS, Holmes AL, Ketterer ME, Hatrsock WJ, Fomchenko E, Katsifas SP, Wise JP Sr. 2003b. Chromium is the proximate genotoxic species in lead chromate-induced genotoxicity in human bronchial cells. Toxicologist 72:217.
23. Wise SS, Holmes AL, Ketterer ME, Hartsock WJ, Fomchenko E, Katsifis SP, Thompson WD, Wise JP Sr. 2004. Chromium is the proximate clastogenic species for lead chromate-induced clastogenicity in human bronchial cells. Mutat Res 560:79-89.
24. Xie H, Wise SS, Holmes AL, Ketterer ME, Hartsock WJ, Wise JP Sr. 2003. Lead chromate genotoxicity is mediated by particle dissolution and not particle internalization. Toxicologist 72:217.
25. Xu J, Wise JP Sr, Patierno SR. 1992. DNA damage induced by lead chromate in cultured mammalian cells. Mutat Res 280:129-136.
26. Zelikoff JT, Li JH, Hartwig A, Wang XW, Costa M, Rossman TG. 1988. Genetic toxicology of lead compounds. Carcinogenesis 9:1727-1732.